Muscle Strength Loss and Its Effect on Knee Cap Motion in Volunteers With Anterior Knee Pain
Vasti Control of Patellofemoral Kinematics in Patients With Chronic Patellofemoral Pain.
2 other identifiers
observational
35
1 country
1
Brief Summary
Background: \- Researchers are interested in how the muscles affect the movement of the knee cap. These muscles may be related to different kinds of knee pain that are not caused by an injury or a disease. Imaging studies such as magnetic resonance imaging (MRI) can be used to look at these muscles. To study these muscles and how they move, researchers will use MRI to look at healthy individuals and individuals with knee cap pain. Objectives: \- To study how changes to the muscles around the knee can influence knee pain. Eligibility:
- Individuals between 18 to 55 years of age who have knee cap pain that cannot be explained by a specific injury or disease.
- Healthy volunteers between 18 and 55 years of age. Design:
- Participants will be screened with a physical exam and medical history.
- This study requires two visits. Each visit will use standard MRI sequences to take images of the knee in motion and at rest.
- On the first visit, the MRI scan will look at the knee in its natural state. Participants will move the knee up and down for 1 to 3 minutes at a time during the scan.
- On the second visit, a local anesthetic agent will be injected into the muscle of the thigh. The anesthetic will block this muscle from generating force for 2 or 3 hours. Participants will move the knee up and down for 1 to 3 minutes at a time during the MRI scan.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 23, 2013
CompletedFirst Posted
Study publicly available on registry
May 24, 2013
CompletedStudy Start
First participant enrolled
May 31, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 19, 2024
CompletedApril 20, 2026
December 10, 2025
11.1 years
May 23, 2013
April 17, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
PF kinematics and the level of pain experience by the subject
The change in patellofemoral kinematics, patellofemoral pain, and quadriceps strength pre- and post-muscle block.
prior to and after a nerve block
Study Arms (2)
1/Control Volunteers
Healthy controls
2/Volunteers with Pain
Subjects with Chronic Idiopathic Patellofemoral Pain
Eligibility Criteria
Participants will be recruited primarily from the greater Washington DC area. It will be advertised through clinicaltrials.gov, social media, flyers, and word of mouth.@@@
You may qualify if:
- Male and female volunteers between the ages of 18 and 55
You may not qualify if:
- All Volunteers
- Any relevant medical problems, including 933 those preventing ambulation
- Any serious injury to the joint being studied, previous surgery on the joint being studiedor extreme pain at the joint being studied or other condition that may explain the presence of PF\_pain (e.g., meniscal tear, arthritis)
- Allergy/hypersensitivity to any local anesthetic agent (e.g., Novocain, lidocaine, bupivacaine, ropivacaine)
- Liver disease
- Open angle glaucoma
- Cardiac arrhythmias, congenital heart disease
- Glucose-6-phosphate dehydrogenase deficiency
- Any female who is pregnant
- A volunteer will be excluded if they have a contraindication to MR imaging. Examples are:
- Metal within their body, which might be expected to concentrate radiofrequency fields or cause tissue damage from twisting in a magnetic field (e.g., aneurysm clip, implanted neural stimulator, implanted cardiac pacemaker or autodefibrillator, cochlear implant, other foreign body (e.g. metal shavings, insulin pump).
- A condition, which would preclude them from participating in an MR imaging study (e.g., paralyzed hemidiaphragm, morbid obesity, severe claustrophobia)
- A condition that presents an unnecessary risk to them or their unborn child (e.g., 953 pregnancy, previous surgery of uncertain type, symptoms of pheochromocytoma or insulinoma)
- Subjects with Chronic Idiopathic Patellofemoral Pai:
- \. Lack of PF\_pain (either no active pain or current pain of \< 6 months duration)
- +3 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National Institutes of Health Clinical Center
Bethesda, Maryland, 20892, United States
Related Publications (3)
Woolf AD, Pfleger B. Burden of major musculoskeletal conditions. Bull World Health Organ. 2003;81(9):646-56. Epub 2003 Nov 14.
PMID: 14710506BACKGROUNDMurphy L, Schwartz TA, Helmick CG, Renner JB, Tudor G, Koch G, Dragomir A, Kalsbeek WD, Luta G, Jordan JM. Lifetime risk of symptomatic knee osteoarthritis. Arthritis Rheum. 2008 Sep 15;59(9):1207-13. doi: 10.1002/art.24021.
PMID: 18759314BACKGROUNDHootman JM, Helmick CG. Projections of US prevalence of arthritis and associated activity limitations. Arthritis Rheum. 2006 Jan;54(1):226-9. doi: 10.1002/art.21562.
PMID: 16385518BACKGROUND
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Frances T Gavelli, Ph.D.
National Institutes of Health Clinical Center (CC)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- NIH
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 23, 2013
First Posted
May 24, 2013
Study Start
May 31, 2013
Primary Completion
July 19, 2024
Last Updated
April 20, 2026
Record last verified: 2025-12-10
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- ICF
- Time Frame
- Data will be shared through data sharing agreements.@@@@@@@@@@@@The start and end date will be determined by the data sharing agreement.
- Access Criteria
- Data will be shared stripped of PII and with IRB approval.
If other investigators wish to use these data, IRB approval will be sought prior to any data sharing. Data sharing will be done under a waiver of informed consent if (1) the previously signed consent form lacked data sharing information or (2) the consent form contained this information and the participant did not ask that his/her data not be shared. Waiver of consent meets the criteria set out in 45 CFR 46.116(d): The research and data sharing involves no more than minimal risk to the subjects.@@@@@@The waiver or alteration will not adversely affect the rights and welfare of the subjects. Data and samples will have personally identifying information removed.@@@The research could not practicably be carried out without the waiver or alteration.@@@Whenever appropriate, the subjects will be provided with additional pertinent information after@@@participation.